BCWORLD PHARM. Co., Ltd. (KOSDAQ: 200780)
South Korea
· Delayed Price · Currency is KRW 5,120.00
+30.00 (0.59%)
Sep 11, 2024, 9:00 AM KST
BCWORLD PHARM. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -6,897 | 2,634 | 281.3 | -1,843 | -1,580 | -1,553 | Upgrade
|
| Depreciation & Amortization | 7,605 | 7,470 | 7,208 | 5,174 | 4,569 | 3,659 | Upgrade
|
| Loss (Gain) From Sale of Assets | -47.16 | -48.91 | 0.32 | 0 | -197.09 | 48.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 64.29 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 32.61 | -13.42 | 535.17 | 229.14 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 215.18 | 223.05 | 34.91 | 49.77 | 67.29 | 82.08 | Upgrade
|
| Other Operating Activities | 3,643 | 642.45 | -1,251 | -2,522 | -3,361 | -1,507 | Upgrade
|
| Change in Accounts Receivable | -165.27 | -1,652 | -1,520 | -1,236 | 1,477 | 4,764 | Upgrade
|
| Change in Inventory | 1,569 | -299.31 | -618.65 | -813.45 | -1,166 | 3,047 | Upgrade
|
| Change in Accounts Payable | 169.68 | -97.11 | 1,381 | -1,420 | -2,002 | 1,617 | Upgrade
|
| Change in Other Net Operating Assets | 1,165 | 2,080 | 767.78 | 1,762 | -3,310 | 1,952 | Upgrade
|
| Operating Cash Flow | 7,289 | 10,938 | 6,883 | -619.83 | -5,502 | 12,110 | Upgrade
|
| Operating Cash Flow Growth | -30.90% | 58.91% | - | - | - | 129.02% | Upgrade
|
| Capital Expenditures | -2,708 | -2,577 | -6,217 | -17,444 | -7,785 | -21,318 | Upgrade
|
| Sale of Property, Plant & Equipment | 71.34 | 64.27 | 192.36 | 106.58 | 157.03 | 3 | Upgrade
|
| Sale (Purchase) of Intangibles | -40.83 | -132.03 | -47.31 | -1,201 | 188.81 | 273.11 | Upgrade
|
| Investment in Securities | -1,495 | -553.23 | -862.35 | -5.74 | -665.37 | 445.01 | Upgrade
|
| Other Investing Activities | 64.82 | 81.06 | 431 | 1,020 | 105.05 | -13.3 | Upgrade
|
| Investing Cash Flow | -4,424 | -3,764 | -6,678 | -17,690 | -8,112 | -20,610 | Upgrade
|
| Long-Term Debt Issued | - | 35,830 | 35,680 | 30,700 | 53,687 | 29,775 | Upgrade
|
| Long-Term Debt Repaid | - | -39,535 | -32,951 | -19,509 | -35,970 | -20,753 | Upgrade
|
| Net Debt Issued (Repaid) | -2,945 | -3,705 | 2,729 | 11,191 | 17,717 | 9,022 | Upgrade
|
| Repurchase of Common Stock | - | - | -806.57 | - | -24.32 | -475.67 | Upgrade
|
| Dividends Paid | -542.73 | -542.73 | -853.86 | -853.86 | -771.83 | -775.33 | Upgrade
|
| Other Financing Activities | -0 | -0 | 3.7 | -0 | 6,000 | - | Upgrade
|
| Financing Cash Flow | -3,488 | -4,248 | 1,073 | 10,337 | 22,921 | 7,771 | Upgrade
|
| Foreign Exchange Rate Adjustments | 34.01 | 38.01 | -1.7 | 48.29 | -311.28 | 23.12 | Upgrade
|
| Net Cash Flow | -589.09 | 2,963 | 1,276 | -7,925 | 8,995 | -706.7 | Upgrade
|
| Free Cash Flow | 4,582 | 8,361 | 666.21 | -18,064 | -13,288 | -9,208 | Upgrade
|
| Free Cash Flow Growth | -26.36% | 1154.97% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 6.28% | 11.13% | 0.92% | -29.10% | -23.30% | -17.88% | Upgrade
|
| Free Cash Flow Per Share | 543.15 | 990.78 | 78.17 | -2115.59 | -1561.59 | -1074.26 | Upgrade
|
| Cash Interest Paid | 4,360 | 4,474 | 2,811 | 1,851 | 1,925 | 415.95 | Upgrade
|
| Cash Income Tax Paid | - | -1,291 | -85.77 | 1,100 | 231.5 | 275.77 | Upgrade
|
| Levered Free Cash Flow | 3,791 | 5,224 | -2,496 | -63,484 | 31,885 | -14,992 | Upgrade
|
| Unlevered Free Cash Flow | 6,949 | 8,495 | -125.88 | -62,129 | 33,397 | -14,151 | Upgrade
|
| Change in Net Working Capital | -1,543 | 243.81 | 2,234 | 47,699 | -37,734 | -3,862 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.